CID 132278
Esculentagenin
Structural Information
- Molecular Formula
- C31H46O8
- SMILES
- C[C@]1(CC[C@@]2(CC[C@@]3(C(=CC(=O)[C@H]4[C@]3(CCC5[C@@]4(C[C@@H]([C@@H]([C@@]5(C)CO)O)O)C)C)[C@H]2C1)C)C(=O)O)C(=O)OC
- InChI
- InChI=1S/C31H46O8/c1-26(25(38)39-6)9-11-31(24(36)37)12-10-29(4)17(18(31)14-26)13-19(33)22-27(2)15-20(34)23(35)28(3,16-32)21(27)7-8-30(22,29)5/h13,18,20-23,32,34-35H,7-12,14-16H2,1-6H3,(H,36,37)/t18-,20+,21?,22-,23+,26-,27+,28+,29-,30-,31+/m1/s1
- InChIKey
- UDGHUYMQCJZOHS-BUPAAZKASA-N
- Compound name
- (2R,4aR,6aR,6aS,6bR,9R,10R,11S,12aS,14bR)-10,11-dihydroxy-9-(hydroxymethyl)-2-methoxycarbonyl-2,6a,6b,9,12a-pentamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-4a-carboxylic acid
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 547.32658 | 225.9 |
[M+Na]+ | 569.30852 | 230.6 |
[M-H]- | 545.31202 | 224.0 |
[M+NH4]+ | 564.35312 | 243.2 |
[M+K]+ | 585.28246 | 227.8 |
[M+H-H2O]+ | 529.31656 | 219.8 |
[M+HCOO]- | 591.31750 | 219.7 |
[M+CH3COO]- | 605.33315 | 247.7 |
[M+Na-2H]- | 567.29397 | 226.5 |
[M]+ | 546.31875 | 222.5 |
[M]- | 546.31985 | 222.5 |
Literature stripe
Patent stripe
No patent data available for this compound.